Reset all filters
01 9Pemigatinib
02 3Ponatinib
03 3Ponatinibhydroklorid
04 3Put It Away
05 1Retifanlimab
06 1Retifanlimab
07 1Ruxolitinib
08 2Ruxolitinib Phosphate
09 2Tafasitamab
10 1Tafasitamabum
Reset all filters
01 1Concentrate For Solution For Infusion
02 3Cream
03 9Film Coated Tablet
04 1Injectable Solution
05 1Powder For Concentrate For Infusion Solution
06 1Powder For Concentrate For Solution For Infusion
07 1Solution For Injection
08 9Tablet
Reset all filters
01 113.5MG
02 213.5mg
03 215MG
04 315mg
05 115mg/g
06 1200MG
07 2200mg
08 130MG
09 230mg
10 14.5MG
11 24.5mg
12 140mg
13 145MG
14 145mg
15 1500mg
16 1500mg/20ml
17 19MG
18 19mg
19 1Blank
Reset all filters
01 8Spain
02 9Sweden
03 9Switzerland
Reset all filters
01 9Iclusig
02 3Minjuvi
03 2Opzelura
04 1Opzelura g
05 9Pemazyre
06 1ZYNYZ
07 1Zynyz
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Tablet
Dosage Strength : 13.5mg
Packaging :
Brand Name : Pemazyre
Approval Date : 26/03/2021
Application Number : 20191122000062
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Tablet
Dosage Strength : 4.5mg
Packaging :
Brand Name : Pemazyre
Approval Date : 26/03/2021
Application Number : 20191122000048
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Tablet
Dosage Strength :
Packaging :
Brand Name : Pemazyre
Approval Date : 26/03/2021
Application Number : 20191122000055
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Limited-Term
Registration Country : Switzerland
Dosage Form : Tablet
Dosage Strength : 4.5mg
Packaging :
Brand Name : Pemazyre
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : Limited-Term
Registration Country : Switzerland
Dosage Form : Tablet
Dosage Strength : 9mg
Packaging :
Brand Name : Pemazyre
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : Limited-Term
Registration Country : Switzerland
Dosage Form : Tablet
Dosage Strength : 13.5mg
Packaging :
Brand Name : Pemazyre
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Dosage Strength : 13.5MG
Packaging :
Brand Name : Pemazyre
Approval Date : 2021-05-10
Application Number : 1211535005
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Dosage Strength : 4.5MG
Packaging :
Brand Name : Pemazyre
Approval Date : 2021-05-07
Application Number : 1211535001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Tablet
Dosage Strength : 9MG
Packaging :
Brand Name : Pemazyre
Approval Date : 2021-05-07
Application Number : 1211535003
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Film Coated Tablet
Dosage Strength : 15MG
Packaging :
Brand Name : Iclusig
Approval Date : 2016-09-13
Application Number : 113839005
Regulatory Info : Authorized
Registration Country : Spain